ASBPW vs ROP
Aspire Biopharma Holdings, Inc. (ASBPW) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Aspire Biopharma Holdings, Inc. (ASBPW) common stock listed on US.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
ASBPW does not have a complete income-statement cache yet.
Latest reported ROP revenue for 2026-06-30 was $4.20B. Net income was $1.68B. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
ASBPW currently screens at market cap $0. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the ASBPW and ROP stock pages for the full models.
Not investment advice.